Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Minority Interest (2022 - 2025)

Historic Minority Interest for P3 Health Partners (PIII) over the last 4 years, with Q3 2025 value amounting to $37.6 million.

  • P3 Health Partners' Minority Interest fell 7376.93% to $37.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.6 million, marking a year-over-year decrease of 7376.93%. This contributed to the annual value of $73.6 million for FY2024, which is 7475.65% down from last year.
  • P3 Health Partners' Minority Interest amounted to $37.6 million in Q3 2025, which was down 7376.93% from $42.7 million recorded in Q2 2025.
  • P3 Health Partners' Minority Interest's 5-year high stood at $1.8 billion during Q1 2022, with a 5-year trough of $37.6 million in Q3 2025.
  • For the 4-year period, P3 Health Partners' Minority Interest averaged around $452.5 million, with its median value being $291.5 million (2023).
  • Per our database at Business Quant, P3 Health Partners' Minority Interest tumbled by 3374.53% in 2023 and then plummeted by 7842.33% in 2025.
  • Quarter analysis of 4 years shows P3 Health Partners' Minority Interest stood at $516.8 million in 2022, then plummeted by 43.59% to $291.5 million in 2023, then tumbled by 74.76% to $73.6 million in 2024, then plummeted by 48.89% to $37.6 million in 2025.
  • Its last three reported values are $37.6 million in Q3 2025, $42.7 million for Q2 2025, and $57.8 million during Q1 2025.